Prostaglandin F-2 alpha receptors (FP) are G protein-coupled receptors that
bind prostaglandin F-2 alpha (PGF(2 alpha)), resulting in the activation o
f an inositol phosphate (IP) second messenger pathway. Alternative mRNA spl
icing generates two FP receptor isoforms. These isoforms, designated FPA an
d FPB, are otherwise identical except for their carboxyl termini. FPB is es
sentially a truncated version of FPA that lacks the 46 carboxyl-terminal am
ino acids, including four putative protein kinase C (PKC) phosphorylation s
ites. Until now, functional differences between these FP receptor isoforms
have not been identified. We now report that pretreatment with the PKC inhi
bitor bisindolylmaleimide I enhanced PGF(2 alpha)-stimulated IP accumulatio
n in transfected cells stably expressing the FPA isoform but not in cells s
tably expressing the FPB isoform. Whole-cell phosphorylation experiments sh
owed a strong agonist-dependent phosphorylation of the FPA isoform but litt
le or no phosphorylation of the FPB. Pretreatment of cells with bisindolylm
aleimide I decreased PGF(2 alpha)-stimulated phosphorylation of the FPA iso
form consistent with a PKC-dependent phosphorylation. In vitro phosphorylat
ion of an FPA carboxyl-terminal fusion protein by recombinant PKC alpha sho
wed that the carboxyl terminus of the FPA is a substrate for PKC. These res
ults suggest that PKC-dependent phosphorylation is responsible for differen
tial regulation of second messenger signaling by FP prostanoid receptor iso
forms.